However, it is important to note that while these validation experiments focus on WTp53 contexts, cancers like oral squamous carcinoma, nasopharyngeal carcinoma, and osteosarcoma often exhibit high p53 mutation rates. The gene discussed is TP53; the disease is osteosarcoma.